Loading...
EKTA B logo

Elekta AB (publ)OM:EKTA B Stock Report

Market Cap SEK 18.2b
Share Price
SEK 47.64
My Fair Value
SEK 53.69
11.3% undervalued intrinsic discount
1Y-33.0%
7D-2.5%
Portfolio Value
​
View

Elekta AB (publ)

OM:EKTA B Stock Report

Market Cap: SEK 18.2b

Elekta (EKTA B) Stock Overview

A medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details

EKTA B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends4/6

Rewards

Trading at 60.3% below our estimate of its fair value

Earnings are forecast to grow 28.57% per year

Risk Analysis

Has a high level of debt

Dividend of 5.04% is not well covered by earnings

Large one-off items impacting financial results

Profit margins (1.5%) are lower than last year (6.3%)


EKTA B Community Fair Values

Create Narrative

See what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.

EKTA B logo
Elekta

European Launches And Chinese Recovery Will Expand Precision Radiotherapy Adoption

Key Takeaways Successful software launches and service expansion are boosting sales growth, margins, and predictable cash flow, especially as global adoption of precision radiotherapy accelerates. Market recovery in China and emerging regions, supported by cost control and strong cancer treatment demand, positions Elekta for sustained earnings and multi-year revenue growth.
View narrative
SEK 53.79
FV
11.4% undervalued intrinsic discount
4.35%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
EKTA B logo
Elekta

Rising Trade Barriers And Competition Will Squeeze MedTech Margins

Key Takeaways Rising global trade barriers, reimbursement pressures, and aggressive competition are constraining margins, threatening earnings predictability, and slowing potential revenue growth across Elekta's markets. Underinvestment in R&D and operational challenges in emerging markets are eroding Elekta's technological edge and compressing both current and future profitability.
View narrative
SEK 34
FV
40.1% overvalued intrinsic discount
1.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EKTA B logo
Elekta

Adaptive Radiotherapy And AI Convergence Will Expand Emerging Markets

Key Takeaways Rapid adoption of advanced platforms and strong momentum in underserved regions position Elekta for outsized revenue growth and improved profit margins. Leadership in precision radiotherapy technologies and digital health creates high-margin, recurring revenues and raises barriers to entry for competitors.
View narrative
SEK 86.58
FV
45.0% undervalued intrinsic discount
7.88%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Elekta AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Elekta
Historical stock prices
Current Share PriceSEK 47.64
52 Week HighSEK 72.50
52 Week LowSEK 40.64
Beta1.03
1 Month Change-4.22%
3 Month Change-0.67%
1 Year Change-33.04%
3 Year Change-24.62%
5 Year Change-58.98%
Change since IPO248.59%

Recent News & Updates

Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Oct 06
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Sep 15
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Recent updates

Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Oct 06
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Sep 15
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

Aug 28
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

There's No Escaping Elekta AB (publ)'s (STO:EKTA B) Muted Revenues

Aug 19
There's No Escaping Elekta AB (publ)'s (STO:EKTA B) Muted Revenues

Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Aug 04
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns

Jul 25
Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns

Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?

May 28
Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?

Does Elekta (STO:EKTA B) Have A Healthy Balance Sheet?

Mar 19
Does Elekta (STO:EKTA B) Have A Healthy Balance Sheet?
User avatar

AI-Powered Iris Technology Will Strengthen Future Prospects

Strong order growth and high book-to-bill ratio provide a solid foundation for future revenue and sales growth.

Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

Feb 27
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

Earnings Miss: Elekta AB (publ) Missed EPS By 5.4% And Analysts Are Revising Their Forecasts

Feb 26
Earnings Miss: Elekta AB (publ) Missed EPS By 5.4% And Analysts Are Revising Their Forecasts

Potential Upside For Elekta AB (publ) (STO:EKTA B) Not Without Risk

Feb 17
Potential Upside For Elekta AB (publ) (STO:EKTA B) Not Without Risk

Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

Feb 03
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?

Jan 17
What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?

Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

Dec 23
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Nov 18
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt

Nov 15
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt

Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Nov 01
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Elekta AB (publ) (STO:EKTA B) Screens Well But There Might Be A Catch

Oct 09
Elekta AB (publ) (STO:EKTA B) Screens Well But There Might Be A Catch

Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Sep 24
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

Sep 09
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20

Should Shareholders Reconsider Elekta AB (publ)'s (STO:EKTA B) CEO Compensation Package?

Aug 30
Should Shareholders Reconsider Elekta AB (publ)'s (STO:EKTA B) CEO Compensation Package?

Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 81% Above Its Share Price

Aug 28
Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 81% Above Its Share Price

Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Aug 15
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns

Jun 19
Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns

What Elekta AB (publ)'s (STO:EKTA B) P/E Is Not Telling You

May 24
What Elekta AB (publ)'s (STO:EKTA B) P/E Is Not Telling You

Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate

May 12
Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate

When Should You Buy Elekta AB (publ) (STO:EKTA B)?

Apr 03
When Should You Buy Elekta AB (publ) (STO:EKTA B)?

Is Elekta (STO:EKTA B) A Risky Investment?

Mar 18
Is Elekta (STO:EKTA B) A Risky Investment?

Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

Feb 22
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20

Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E

Feb 20
Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E

Return Trends At Elekta (STO:EKTA B) Aren't Appealing

Feb 08
Return Trends At Elekta (STO:EKTA B) Aren't Appealing

Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price

Jan 03
Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price

Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Dec 18
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Dec 01
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20

Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Nov 11
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger

Nov 09
Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger

Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Oct 28
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20

Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?

Oct 26
Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?

Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Oct 14
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20

Shareholder Returns

EKTA BSE Medical EquipmentSE Market
7D-2.5%-3.3%-0.5%
1Y-33.0%-21.3%-0.6%

Return vs Industry: EKTA B underperformed the Swedish Medical Equipment industry which returned -20.8% over the past year.

Return vs Market: EKTA B underperformed the Swedish Market which returned -1.2% over the past year.

Price Volatility

Is EKTA B's price volatile compared to industry and market?
EKTA B volatility
EKTA B Average Weekly Movement4.2%
Medical Equipment Industry Average Movement6.8%
Market Average Movement5.7%
10% most volatile stocks in SE Market11.6%
10% least volatile stocks in SE Market2.9%

Stable Share Price: EKTA B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: EKTA B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19724,485Jakob Just-Bomholtwww.elekta.com

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite.

Elekta AB (publ) Fundamentals Summary

How do Elekta's earnings and revenue compare to its market cap?
EKTA B fundamental statistics
Market capSEK 18.20b
Earnings (TTM)SEK 274.00m
Revenue (TTM)SEK 17.84b
66.4x
P/E Ratio
1.0x
P/S Ratio

Is EKTA B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EKTA B income statement (TTM)
RevenueSEK 17.84b
Cost of RevenueSEK 11.12b
Gross ProfitSEK 6.71b
Other ExpensesSEK 6.44b
EarningsSEK 274.00m

Last Reported Earnings

Jul 31, 2025

Next Earnings Date

Nov 26, 2025

Earnings per share (EPS)0.72
Gross Margin37.64%
Net Profit Margin1.54%
Debt/Equity Ratio72.0%

How did EKTA B perform over the long term?

See historical performance and comparison

Dividends

5.0%
Current Dividend Yield
335%
Payout Ratio

Does EKTA B pay a reliable dividends?

See EKTA B dividend history and benchmarks
When do you need to buy EKTA B by to receive an upcoming dividend?
Elekta dividend dates
Ex Dividend DateMar 05 2026
Dividend Pay DateMar 11 2026
Days until Ex dividend140 days
Days until Dividend pay date146 days

Does EKTA B pay a reliable dividends?

See EKTA B dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/14 12:39
End of Day Share Price 2025/10/14 00:00
Earnings2025/07/31
Annual Earnings2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elekta AB (publ) is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Alexander KlebanBarclays
Sally TaylorBarclays